Australia markets open in 3 hours 25 minutes

Cellectar Biosciences Inc (NV4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.7000+0.3200 (+13.45%)
At close: 08:08PM CEST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-50,984
-37,983
-28,601
-24,122
-15,094
-
Depreciation & amortisation
238.308
192.375
148.435
149.915
141.453
-
Stock-based compensation
2,456
2,410
1,453
1,124
467.541
-
Change in working capital
304.51
3,476
1,684
198.761
671.239
-
Other working capital
-39,441
-33,241
-25,448
-22,710
-13,995
-
Other non-cash items
59.658
58.051
90.432
77.721
66.476
-
Net cash provided by operating activities
-38,555
-32,377
-25,222
-22,569
-13,933
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-864.038
-225.971
-141.361
-62.353
-
Net cash used for investing activities
-885.671
-864.038
-225.971
-141.361
-62.353
-
Cash flows from financing activities
Debt repayment
-
-
-
-
0
-2.213
Common stock issued
-
-
9,611
34.873
59,719
9,025
Net cash used provided by (used for) financing activities
66,789
22,940
9,611
1,249
60,546
-
Net change in cash
27,348
-10,301
-15,838
-21,461
46,551
-
Cash at beginning of period
12,683
19,866
35,704
57,165
10,615
-
Cash at end of period
40,031
9,565
19,866
35,704
57,165
-
Free cash flow
Operating cash flow
-38,555
-32,377
-25,222
-22,569
-13,933
-
Capital expenditure
-
-864.038
-225.971
-141.361
-62.353
-
Free cash flow
-39,441
-33,241
-25,448
-22,710
-13,995
-